|
Issue |
Title |
|
Vol 6, No 2 (2025) |
"Cardiogenic diabetes": Known influence, unknown mechanisms |
Abstract
PDF (Rus)
|
T. Yu. Demidova, S. V. Panteleeva, F. O. Ushanova |
|
Vol 6, No 2 (2025) |
Insulin resistance as a key risk factor for cardiovascular complications in prediabetes: Early therapeutic options |
Abstract
PDF (Rus)
|
D. V. Skuridina, T. Yu. Demidova, Y. S. Chasovskaya |
|
Vol 6, No 2 (2025) |
Cardiac arrhythmias and diabetes mellitus: What a clinician needs to know |
Abstract
PDF (Rus)
|
M. N. Nadybina, F. O. Ushanova, T. Ya. Izmaylova |
|
Vol 6, No 2 (2025) |
Cardiovascular effects of semaglutide: Multifaceted mechanisms of systemic organoprotection |
Abstract
PDF (Rus)
|
T. Yu. Demidova, M. Ya. Izmailova, M. A. Alieva |
|
Vol 6, No 2 (2025) |
Non-alcoholic fatty liver disease as a link in the cardiometabolic continuum: Focus on hypertriglyceridemia |
Abstract
PDF (Rus)
|
T. Yu. Demidova, A. R. Bagilova, F. O. Ushanova |
|
Vol 6, No 2 (2025) |
The role of intensive blood pressure control in diabetes mellitus |
Abstract
PDF (Rus)
|
S. V. Panteleeva, M. Ya. Izmailova |
|
Vol 6, No 2 (2025) |
Outcomes reported by patients during de-intensification of complex insulin therapy regimens for type 2 diabetes mellitus |
Abstract
PDF (Rus)
|
E. A. Yanovskaya, M. E. Yanovskaya |
|
Vol 6, No 1 (2025) |
Ultrasonic conductivity of the skull bones as a factor limiting the performance of operations using focused ultrasound in central nervous system diseases: Endocrinologist's view |
Abstract
PDF (Rus)
|
G. M. Sakharova, R. M. Galimova, A. N. Khatmullina, D. I. Nabiullina, A. A. Bikbulatova, I. V. Buzaev, D. Sh. Avzaletdinova |
|
Vol 6, No 1 (2025) |
Long-term prospects of therapy with dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus |
Abstract
PDF (Rus)
|
T. Yu. Demidova |
|
Vol 6, No 1 (2025) |
Prediabetes: Risk factors instead of complaints? |
Abstract
PDF (Rus)
|
I. A. Barsukov, A. A. Demina |
|
Vol 6, No 1 (2025) |
Metabolic disorders and infertility |
Abstract
PDF (Rus)
|
G. B. Dikke |
|
Vol 6, No 1 (2025) |
Current understanding of the phenotypes of chronic kidney disease in patients with diabetes mellitus |
Abstract
PDF (Rus)
|
T. Yu. Demidova, A. S. Teplova, A. S. Ochirova |
|
Vol 6, No 1 (2025) |
Diversity of pleiotropic effects of semaglutide: From potential mechanisms to real clinical outcomes |
Abstract
PDF (Rus)
|
T. Yu. Demidova, M. Ya. Izmailova, M. E. Shirnina |
|
Vol 5, No 4 (2024) |
Complications of lower extremities in patients with diabetes mellitus |
Abstract
PDF (Rus)
|
E. Yu. Komelyagina, M. B. Antsiferov |
|
Vol 5, No 4 (2024) |
Adrenocortical cancer: Prognosis, treatment and immune microenvironment |
Abstract
PDF (Rus)
|
N. V. Pachuashvili, E. E. Porubaeva, L. S. Urusova |
|
Vol 5, No 4 (2024) |
Optimization of physical activity in the patients with type 2 diabetes mellitus |
Abstract
PDF (Rus)
|
S. I. Motkova, M. V. Gurkina, E. V. Surkova, L. V. Savelyeva, G. R. Galstyan |
|
Vol 5, No 4 (2024) |
The role of DPP-4 inhibitors in achieving glycemic control and the effect on aging processes in patients with type 2 diabetes mellitus |
Abstract
PDF (Rus)
|
D. V. Skuridina, T. Yu. Demidova, M. Y. Izmaylova |
|
Vol 5, No 4 (2024) |
The role of the kidneys in glucose homeostasis: Mechanisms of effectiveness of sodium-glucose cotransporter type 2 inhibitors |
Abstract
PDF (Rus)
|
T. Yu. Demidova, O. A. Kislyak, G. Lobanova, L. D. Kharchilava |
|
Vol 5, No 4 (2024) |
Long-term efficacy of metformin and primary prevention of complications of type 2 diabetes mellitus: Results from 42-year UKPDS follow-up |
Abstract
PDF (Rus)
|
F. O. Ushanova, T. Ya. Izmailova, T. L. Bogacheva |
|
Vol 5, No 4 (2024) |
Medical treatment of obesity: Modern approaches and prospects |
Abstract
PDF (Rus)
|
V. V. Titova, F. O. Ushanova, T. Yu. Demidova |
|
Vol 5, No 4 (2024) |
Interdisciplinary approach to the management of diabetic retinopathy: The role of ophthalmologist and endocrinologist |
Abstract
PDF (Rus)
|
T. Yu. Demidova, E. E. Shadrichev, N. N. Grigorieva, V. A. Fischer, F. O. Ushanova, M. N. Nadybina |
|
Vol 5, No 4 (2024) |
The role of glucagon-like peptide-1 receptor agonists in cardiometabolic health management |
Abstract
PDF (Rus)
|
T. Yu. Demidova, I. G. Nikitin, O. A. Kislyak, A. V. Starodubova |
|
Vol 5, No 4 (2024) |
Stroke prevention in patients with prediabetes and diabetes mellitus: New opportunities |
Abstract
PDF (Rus)
|
O. D. Ostroumova, N. A. Shatalova, A. I. Kochetkov, T. V. Filippova, I. F. Krotkov, O. A. Milovanova |
|
Vol 5, No 3 (2024) |
Replacement therapy for hypothyroidism in special groups of patients |
Abstract
PDF (Rus)
|
T. B. Morgunova, E. G. Ryzhkova, M. I. Strokova, V. V. Fadeyev |
|
Vol 5, No 3 (2024) |
From metabolism to pathology: тhe role of sodium-glucose cotransporter-1 in the pathogenesis of type 2 diabetes mellitus |
Abstract
PDF (Rus)
|
T. Yu. Demidova, A. S. Teplova, E. V. Stepanova, D. S. Amirian |
|
Vol 5, No 3 (2024) |
The interplay of metabolically associated fatty liver disease and carbohydrate metabolism disorders: Current understanding of pathogenesis and treatment |
Abstract
PDF (Rus)
|
A. V. Murasheva, A. A. Mikhailova, K. A. Pogosian, K. A. Golovatyuk, O. S. Fuks, T. L. Karonova |
|
Vol 5, No 3 (2024) |
Intensive start of therapy in modern strategies for managing type 2 diabetes mellitus |
Abstract
PDF (Rus)
|
F. O. Ushanova, T. Yu. Demidova, Yu. S. Chasovskaya |
|
Vol 5, No 3 (2024) |
The role of superfast insulin analogues in diabetes mellitus |
Abstract
PDF (Rus)
|
T. Yu. Demidova, G. R. Galstyan, A. N. Levitskaya |
|
Vol 5, No 3 (2024) |
Sodium-glucose co-transporter type 2 inhibitors and non-alcoholic fatty liver disease |
Abstract
PDF (Rus)
|
K. M. Shubina, A. M. Alieva, I. G. Nikitin |
|
Vol 5, No 3 (2024) |
DPP-4 inhibitors in modern algorithms for the management of type 2 diabetes mellitus: focus on early combined pathogenetic therapy |
Abstract
PDF (Rus)
|
T. Yu. Demidova, F. O. Ushanova |
|
Vol 5, No 1 (2024) |
The therapeutic potential of the use of gliclazide MV in combination with COVID-19 and type 2 diabetes mellitus |
Abstract
PDF (Rus)
|
D. V. Belikina, T. A. Nekrasova, L. G. Strongin, E. M. Durygina, M. Yu. Rodina |
|
Vol 5, No 1 (2024) |
The effect of semaglutide on body weight in patients with type 2 diabetes mellitus |
Abstract
PDF (Rus)
|
T. Yu. Demidova, V. V. Titova |
|
Vol 5, No 1 (2024) |
Adrenocortical cancer: principles of morphological diagnostics for the endocrinologist |
Abstract
PDF (Rus)
|
E. E. Porubayeva, N. V. Pachuashvili, L. S. Urusova |
|
Vol 5, No 1 (2024) |
Ovarian reserve in obese patients: where do the eggs disappear? |
Abstract
PDF (Rus)
|
K. V. Azizova, S. V. Dora, Yu. Sh. Khalimov, A. R. Volkova, T. A. Cheboksarova |
|
Vol 5, No 1 (2024) |
Biochemical bases of the organoprotective properties of metformin |
Abstract
PDF (Rus)
|
A. S. Teplova, V. V. Titova, A. I. Tenchurina |
|
Vol 5, No 1 (2024) |
Review of international clinical guidelines for the management of hypertension in patients with diabetes mellitus? |
Abstract
PDF (Rus)
|
F. O. Ushanova, T. Yu. Demidova, S. V. Panteleeva |
|
Vol 5, No 1 (2024) |
Diagnosis and treatment of osteoporosis: a paradigm shift |
Abstract
PDF (Rus)
|
K. G. Lobanova, F. O. Ushanova |
|
Vol 4, No 1 (2023) |
Chronic hypoparathyroidism: clinical manifestations, complications and impact on the quality of life |
Abstract
PDF (Rus)
|
E. V. Kovaleva, A. K. Eremkina, N. G. Mokrysheva |
|
Vol 4, No 2 (2023) |
Difficulties in diagnosing primary hyperaldosteronism |
Abstract
PDF (Rus)
|
T. Yu. Demidova, V. V. Titova |
|
Vol 4, No 2 (2023) |
The evolution of body composition assessment: from body mass index to body composition profiling |
Abstract
PDF (Rus)
|
E. V. Kiseleva, E. A. Pigarova, N. G. Mokrysheva |
|
Vol 4, No 2 (2023) |
Pecularities of treatment of elderly patients with type 2 diabetes mellitus |
Abstract
PDF (Rus)
|
T. Yu. Demidova, A. S. Kochina |
|
Vol 4, No 2 (2023) |
Principles of cardiovascular risk management in perimenopausal women with type 2 diabetes |
Abstract
PDF (Rus)
|
F. O. Ushanova, T. Yu. Demidova, T. N. Korotkova |
|
Vol 4, No 2 (2023) |
Prediabetes: a risk factor for cardiovascular diseases and a window of opportunity for their prevention |
Abstract
PDF (Rus)
|
T. Yu. Demidova, V. M. Plakhotnyaya |
|
Vol 4, No 2 (2023) |
Role of metabolic surgery in remission of type 2 diabetes mellitus in patients with obesity |
Abstract
PDF (Rus)
|
V. S. Mozgunova, G. V. Semikova, A. R. Volkova, E. N. Ostroukhova, B. G. Lukichev |
|
Vol 4, No 1 (2023) |
Hypercalcemia syndrome: differential diagnostic search and treatment tactics |
Abstract
PDF (Rus)
|
T. Yu. Demidova, K. G. Lobanova, T. N. Korotkova |
|
Vol 4, No 1 (2023) |
Type 2 diabetes mellitus, non-alcoholic fatty liver disease and cardiovascular disease: causal relationships and the role of anti-diabetic drugs |
Abstract
PDF (Rus)
|
T. Yu. Demidova, D. V. Skuridina, E. S. Pervushina |
|
Vol 4, No 1 (2023) |
Glucometry and self-control skills as necessary components in the management of a patient with prediabetes in the outpatient settings |
Abstract
PDF (Rus)
|
V. N. Larina |
|
Vol 4, No 1 (2023) |
The role of sodium-glucose cotransporter type 2 inhibitors on the path to cardiovascular well-being in type 2 diabetes mellitus and chronic kidney disease |
Abstract
PDF (Rus)
|
T. Yu. Demidova, D. V. Skuridina |
|
Vol 4, No 1 (2023) |
Modern possibilities and prospects in the treatment of adrenal insufficiency |
Abstract
PDF (Rus)
|
F. O. Ushanova, T. Yu. Demidova, T. N. Korotkova |
|
1 - 49 of 49 Items |
|